You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Netarsudil Ophthalmic Solution

Showing 1 - 25 of 5,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Setagaya-Ku (Netarsudil ophthalmic solution 0.02%, Ripasudil HCl

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Netarsudil ophthalmic solution 0.02%
  • Ripasudil hydrochloride hydrate ophthalmic solution 0.4%
  • Setagaya-Ku, Tokyo, Japan
    Seijo Clinic
Aug 29, 2021

Fuchs Endothelial Dystrophy Trial in Indianapolis (Netarsudil Ophthalmic Solution, Placebo)

Completed
Has Results
  • Fuchs Endothelial Dystrophy
  • Netarsudil Ophthalmic Solution
  • Placebo
  • Indianapolis, Indiana
    Price Vision Group
Sep 23, 2021

Rhopressa on Episcleral and Retinal Blood Flow in Ocular

Completed
  • Ocular Hypertension
  • Suspect Glaucoma
  • Netarsudil ophthalmic solution 0.02% one drop nightly for 1-2 weeks
  • Baltimore, Maryland
  • +3 more
Mar 24, 2022

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial (Netarsudil Ophthalmic)

Not yet recruiting
  • Rhegmatogenous Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Netarsudil Ophthalmic
  • (no location specified)
Sep 9, 2023

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution

Not yet recruiting
  • Rhegmatogenous Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
  • Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
  • Philadelphia, Pennsylvania
    Wills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (Netarsudil Ophthalmic Solution 0.01%, Netarsudil Ophthalmic Solution

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Netarsudil Ophthalmic Solution 0.01%
  • +3 more
  • Ichinomiya-shi, Aichi, Japan
  • +24 more
Sep 23, 2020

Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

Active, not recruiting
  • Glaucoma
  • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
  • Mission Hills, California
  • +20 more
Jan 6, 2023

Fuchs' Endothelial Dystrophy, Cataract Trial in Boston (Netarsudil 0.02% Ophthalmic Solution)

Completed
  • Fuchs' Endothelial Dystrophy
  • Cataract
  • Netarsudil 0.02% Ophthalmic Solution
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Jan 24, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Netarsudil/Latanoprost 0.02%/0.005%, GANFORT®)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Graz, Austria
  • +67 more
Jan 24, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Netarsudil Ophthalmic Solution 0.02%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Netarsudil Ophthalmic Solution 0.02%
  • Huntington Beach, California
  • +21 more
Sep 8, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Fuchs' Endothelial Dystrophy Trial in Boston (Netarsudil Ophthalmic)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Netarsudil Ophthalmic
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Aug 23, 2022

Healthy Adult Males Volunteers Trial in Osaka (STN1012600 ophthalmic solution 0.002%)

Recruiting
  • Healthy Adult Males Volunteers
  • STN1012600 ophthalmic solution 0.002%
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Jun 6, 2023

Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial (5% Tavilermide ophthalmic solution, Vehicle ophthalmic

Not yet recruiting
  • Dry Eye Syndromes
  • +2 more
  • 5% Tavilermide ophthalmic solution
  • Vehicle ophthalmic solution
  • (no location specified)
Apr 27, 2023

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

Recruiting
  • Corneal Epithelial Degeneration
  • TTHX1114(NM141) Ophthalmic Solution
  • Cypress, California
    Trefoil Clinical Site #132
Mar 3, 2023

Open Angle Glaucoma Trial (NCX 470, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • NCX 470
  • Placebo
  • (no location specified)
Jul 6, 2023

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting
  • Cataract
  • +2 more
  • Bimatoprost Implant System (High Dose)
  • +4 more
  • Glendale, Arizona
    Arizona Advanced Eye Research Institute
Nov 8, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Rhegmatogenous Retinal Detachment - Macula Off Trial (ONL1204 Ophthalmic Solution, Sham treatment)

Not yet recruiting
  • Rhegmatogenous Retinal Detachment - Macula Off
  • ONL1204 Ophthalmic Solution
  • Sham treatment
  • (no location specified)
Feb 15, 2023

0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in

Not yet recruiting
  • Post Operative Endophthalmitis
  • Moxifloxacin hydrochloride ophthalmic solution
  • (no location specified)
Jan 11, 2023

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023